Birchview Capital, LP’s Protagonist Therapeutics Inc Position
Does Birchview Capital, LP own Protagonist Therapeutics Inc (PTGX)? Yes — 35.0K shares worth $4M (+2.10% of its 13F portfolio) as of Q1 2026, down from 55.0K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
35.0K
% of Portfolio
+2.10%
Quarters Held
21
currently held
Position History PTGX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 35.0K | $4M | +2.10% |
| Q4 2025 | 55.0K | $5M | +2.81% |
| Q3 2025 | 48.0K | $3M | +2.41% |
| Q2 2025 | 48.0K | $3M | +2.63% |
| Q1 2025 | 48.0K | $2M | +2.02% |
| Q4 2024 | 48.0K | $2M | +1.51% |
| Q3 2024 | 48.0K | $2M | +1.87% |
| Q2 2024 | 48.0K | $2M | +1.54% |
| Q1 2024 | 48.0K | $1M | +1.13% |
| Q4 2023 | 48.0K | $1M | +0.86% |
| Q3 2023 | 38.0K | $633,840 | +0.54% |
| Q2 2023 | 38.0K | $1M | +0.79% |
| Q1 2023 | 38.0K | $874 | +0.68% |
| Q4 2022 | 38.0K | $415 | +0.29% |
| Q3 2022 | 38.0K | $320,000 | +0.23% |
| Q2 2022 | 38.0K | $301,000 | +0.22% |
| Q1 2022 | 38.0K | $900,000 | +0.65% |
| Q4 2021 | 38.0K | $1M | +0.84% |
| Q3 2021 | 38.0K | $673,000 | +0.46% |
| Q2 2021 | 10.0K | $449,000 | +0.27% |
| Q1 2021 | 10.0K | $259,000 | +0.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of PTGX.